The Progressive Supranuclear Palsy Market analysis reveals an accelerating momentum in research and clinical advancements targeting rare neurodegenerative disorders. PSP, a condition marked by the deterioration of brain cells leading to motor dysfunction, vision problems, and cognitive decline, has long posed challenges for the medical community. However, advancements in neuroimaging, biomarker...